Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen

The efficacy of the B-cell-depleting agent rituximab has been reported in immune diseases but relapses are frequent, suggesting the need for repeated infusions. The B-cell activating factor (BAFF) is an important factor for B cell survival, class switch recombination and selection of autoreactive B...

Descripción completa

Detalles Bibliográficos
Autores principales: Hébert, Vivien, Maho-Vaillant, Maud, Golinski, Marie-Laure, Petit, Marie, Riou, Gaëtan, Boyer, Olivier, Musette, Philippe, Calbo, Sébastien, Joly, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160507/
https://www.ncbi.nlm.nih.gov/pubmed/34054835
http://dx.doi.org/10.3389/fimmu.2021.666022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160507/
https://www.ncbi.nlm.nih.gov/pubmed/34054835
http://dx.doi.org/10.3389/fimmu.2021.666022

Ejemplares similares